Author

Meng Li

Shenyang Pharmaceutical UniversityORCID 0000-0002-2425-326XUnclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Meng Li12 papers · Jilin University

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Chutong TianiD· 1 shared Fengli Xia· 1 shared Guanting Li· 1 shared Hongying Xiao· 1 shared Jianbin Shi· 1 shared Jiaxin ZhangiD· 1 shared Ken‐ichiro KameiiD· 1 shared Shunzhe Zheng· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Chutong TianORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyJournal of Controlled ReleasePeer-reviewedJun 8, 2024

Dual-targeted nanoparticulate drug delivery systems for enhancing triple-negative breast cancer treatment

Shunzhe Zheng, Meng Li, Wenqian Xu…·Ken‐ichiro Kamei

This paper develops a dual-targeted nanoparticulate drug delivery system (SJNP) combining SN38 and JQ-1 to enhance triple-negative breast cancer treatment by disrupting DNA repair and mitochondrial function.

20 citations

mouseexperimental assay

𝕏 PostBluesky